Literature DB >> 7768767

Linkage of vancomycin and high-level gentamicin resistance genes on the same plasmid in a clinical isolate of Enterococcus faecalis.

N Woodford1, B L Jones, Z Baccus, H A Ludlam, D F Brown.   

Abstract

A transferable 55-MDa plasmid which encoded resistance to both vancomycin and high concentrations of gentamicin was identified in a clinical isolate of Enterococcus faecalis. The plasmid hybridized with probes for the vanB and aac6'aph2" resistance genes. This is the first report of linkage of glycopeptide and high-level aminoglycoside resistance genes in an Enterococcus sp.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7768767     DOI： 10.1093/jac/35.1.179

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


  17 in total

1.  Heterogeneity in the vanB gene cluster of genomically diverse clinical strains of vancomycin-resistant enterococci.

Authors:  K H Dahl; G S Simonsen; O Olsvik; A Sundsfjord
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

2.  Outbreak of vancomycin-resistant Enterococcus faecium of the phenotype VanB in a hospital in Warsaw, Poland: probable transmission of the resistance determinants into an endemic vancomycin-susceptible strain.

Authors:  M Kawalec; M Gniadkowski; M Zaleska; T Ozorowski; L Konopka; W Hryniewicz
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

3.  Transferable, plasmid-mediated vanB-type glycopeptide resistance in Enterococcus faecium.

Authors:  L B Rice; L L Carias; C L Donskey; S D Rudin
Journal:  Antimicrob Agents Chemother       Date:  1998-04       Impact factor: 5.191

Review 4.  Current perspectives on glycopeptide resistance.

Authors:  N Woodford; A P Johnson; D Morrison; D C Speller
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

5.  Heterogeneous expression of glycopeptide resistance in enterococci associated with transfer of vanB.

Authors:  M K Hayden; R N Picken; D F Sahm
Journal:  Antimicrob Agents Chemother       Date:  1997-04       Impact factor: 5.191

6.  Vancomycin-resistant Enterococcus faecium strain carrying the vanB2 gene variant in a Polish hospital.

Authors:  M Kawalec; M Gniadkowski; U Zielińska; W Kłos; W Hryniewicz
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

7.  Characterization of vancomycin-resistant Enterococcus faecium isolates from the United States and their susceptibility in vitro to dalfopristin-quinupristin.

Authors:  G M Eliopoulos; C B Wennersten; H S Gold; T Schülin; M Souli; M G Farris; S Cerwinka; H L Nadler; M Dowzicky; G H Talbot; R C Moellering
Journal:  Antimicrob Agents Chemother       Date:  1998-05       Impact factor: 5.191

8.  Selection of a teicoplanin-resistant Enterococcus faecium mutant during an outbreak caused by vancomycin-resistant enterococci with the vanB phenotype.

Authors:  M Kawalec; M Gniadkowski; J Kedzierska; A Skotnicki; J Fiett; W Hryniewicz
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

9.  High prevalence of VanB2 vancomycin-resistant Enterococcus faecium in Taiwan.

Authors:  J J Lu; C L Perng; M F Ho; T S Chiueh; W H Lee
Journal:  J Clin Microbiol       Date:  2001-06       Impact factor: 5.948

10.  Identification and characterization of vanB2 glycopeptide resistance elements in enterococci isolated in Scotland.

Authors:  K F McGregor; H K Young
Journal:  Antimicrob Agents Chemother       Date:  2000-09       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.